Found 5 matching trials
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin PHASE3 Chronic hepatitis C infection is one of the leading causes of chronic liver...
Show More Location
University of Alabama - Knollwood Physician's Group Bldg.
Learn More & Join Trial
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B PHASE4 The purpose of this study is to determine the optimal treatment duration of...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin PHASE3 Chronic hepatitis C infection is one of the leading causes of chronic liver...
Show More Location
University of Alabama - Knollwood Physician's Group
Learn More & Join Trial
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin. PHASE3 The purpose of the study was to determine safety and efficacy of 48 weeks t...
Show More Learn More & Join Trial
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients PHASE1 REP 9AC (REP 2055) is a nucleic acid polymer (NAP) with entry and post-entr...
Show More Location
Farabi General Hospital
Learn More & Join Trial